aTyr Pharma, Inc.
LIFE
|
$1.7
-2.3%
-2.35%
300K
|
Health Technology
(0.0% 1d) (-13.0% 1m) (-11.5% 1y) (0.0% 2d) (0.0% 3d) (-4.0% 7d) (21.82% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 115,499,430
http://www.atyrpharma.com
Sec Filling | Patents | 44 employees
(US) aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. It operates in a single accounting segment. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
glass diagnostics
add to watch list Paper trade email alert is off
Press-releases
aTyr Pharma to Participate in April Investor Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -3.05%
pharma
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 0.0%
H: 24.07%
C: 22.84%
pharma year update results
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -5.0%
pharma conference year financial results
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 1.6%
H: 5.24%
C: 3.14%
pharma program trial
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 0.0%
H: 3.16%
C: 2.53%
pharma cell
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Published: 2024-01-18 (Crawled : 13:00) - globenewswire.com
WDAY F | $259.63 -1.54% -1.54% 1.2M
|
Technology Services
|
| O: 0.71%
H: 0.87%
C: 0.84%
PODD | $173.94 -0.73% -0.73% 820K
|
Health Technology
|
| O: 0.95%
H: 0.87%
C: 0.54%
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: -4.05%
pharma
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: -1.79%
H: 6.36%
C: 1.36%
pharma preclinical efzofitimod
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 0.87%
H: 0.86%
C: -3.45%
pharma update results
Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players - Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences
Published: 2023-11-02 (Crawled : 21:00) - prnewswire.com
UTHR | $235.08 1.07% 1.12% 330K
|
Health Technology
|
| O: 0.73%
H: 0.63%
C: -2.35%
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 0.78%
H: 1.54%
C: 0.0%
sciences growth market
aTyr Pharma to Present at November Investor Conferences
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.7 -2.3% -2.35% 300K
|
Health Technology
|
| O: 5.6%
H: 0.0%
C: -6.82%
pharma
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 45% | 55% |
Top 10 Gainers
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
PTN | $1.82 -5.21% 15.38% 290K
|
Health Technology
VIAO | $0.308 -26.67% 12.01% 390K
|
Electronic Technology
HNRA | $2.36 -9.58% 11.86% 220K
|
n/a
HYLN 4 | $1.32 -7.04% 8.33% 800K
|
Producer Manufacturing
UMAC | $1.85 -2.12% 8.11% 6.1K
|
AMX | $18.02 -0.17% 7.32% 580
|
Communications
BQ | $0.2429 -6.07% 6.63% 15
|
Consumer Non-Durables
LBRT 4 | $22.1 -1.6% 6.29% 2.1M
|
Industrial Services
CRT | $12.73 -2.82% 6.28% 40K
|
Energy Minerals
Last 48 Hours Insiders Buying
RMCF | $3.6492 2.51% -7.2% 7.1K
|
Consumer Non-Durables
|
20:10